Analystreport

Rhythm Pharmaceuticals (RYTM) had its price target lowered by Wells Fargo & Company from $145.00 to $136.00. They now have an "overweight" rating on the stock.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com